Cablivi

Product manufactured by Genzyme Corporation

Application Nr Approved Date Route Status External Links
BLA761112 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Cablivi Is Indicated For The Treatment Of Adult Patients With Acquired Thrombotic Thrombocytopenic Purpura (attp), In Combination With Plasma Exchange And Immunosuppressive Therapy. Cablivi Is A Von Willebrand Factor (vwf)-Directed Antibody Fragment Indicated For The Treatment Of Adult Patients With Acquired Thrombotic Thrombocytopenic Purpura (attp), In Combination With Plasma Exchange And Immunosuppressive Therapy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Caplacizumab

Comments